Background: Nicotine contributes to tumorigenesis through stimulation of nicotinic acetylcholine receptors (nAChRs) in head and neck squamous cell carcinoma (SCC). Although many factors have been found to be involved in the pathogenesis of head and neck cancer, the effect of nAChRs is still unclear. The study provides information on different subtypes in SCC and normal mucosa (NM) and their clinicopathological correlation to tumor progression. Methods: SCC (n = 34) of oropharynx, hypopharynx, larynx and corresponding NM (n = 38) were analyzed by quantitative real-time polymerase chain reaction, immunoblotting and immunohistochemistry and correlated to tumor grading and Union for International Cancer Control (UICC) stage. Results: nAChR subtypes α1, α3, α5 and α7 were found in NM and SCC of the upper aerodigestive tract with high rates of α1 and α5 in SCC. An overexpression of α1 was found in laryngeal and hypopharyngeal SCC, while α3 and α7 subunits were downregulated. The expression of α1 and α5 subunits increased with tumor progression. Conclusion: The nAChR subunit pattern shows a difference between NM and SCC and changes in the process of tumor progression. Therefore, it is conceivable that it contributes to tumorigenesis. The findings provide a basis for further studies in prognostic assessment and identifying carcinogenic changes from NM to SCC.
Introduction
Physiologically, nicotinic acetylcholine receptors (nAChRs) act as regulators of growth factor release [1] and are located in the plasma membrane and comprise subunits forming hetero-or homopentamers. The homomeric form consists of five identical α subunits and the heteromeric form consists of a combination of α and β subunits [2] . Epithelial cells such as epidermal keratinocyts express α3, α5, α7 and β2 [3] . Nicotine as risk factor for head and neck cancer mimics the actions of acetylcholine by binding to the α subunits [4] resulting in a release of enzymes such as protein kinase C (PKC), the Raf-1-mitogen-activated protein (MAP), extracellular signal-regulated kinase (ERK) [5] , phospatidylinositol-3-kinase (PI3K) [6] or janus kinase-2 (JAK-2) [7] . Thus, cell proliferation, apoptosis, migration, cell differentiation or angiogenesis are regulated [8, 9] . A proliferative effect is played directly by cholinergic agonists at nAChRs. Castillo-González et al. [10] found that low expression of acetylcholine esterase, as a key protein in the non-neuronal cholinergic system, is associated with low prognosis and shorter survival by signaling downstream events that may favor tumor growth and aggressiveness. nAChRs of a different subunit composition lead to different signaling mechanisms [11] . The effect depends on the cell type [12] and on the course of cell and tissue differentiation [13] . In order to understand pathologies with nAChR involvement, it is important to know the nAChR subunit composition and the allocation to certain body regions. This study helps understand mucosal cell deregulation in squamous cell carcinoma (SCC) of the head and neck region. We present the first characterization and differential localization (oropharynx, hypopharynx, larynx) of four different nAChRs (α1, α3, α5, α7) in head and neck SCC compared to normal mucosa (NM) at both a transcriptional and translational level combined with an immunohistochemical analysis. The results are correlated to clinicopathological characteristics and are discussed in the context of a potential clinical use of nAChRs in the future.
Materials and Methods

Tissue Samples
Surgically derived tissue specimens from 34 patients with SCC of the head and neck and corresponding samples of NM of the same region distant to the tumor were taken and stored. No patient had received radio(chemo)therapy prior to the intervention. The pathologist confirmed all cases as SCC. All patients were regular tobacco consumers (median of 25 pack-years) with a median age of 59 years. All patients gave written consent to tissue usage and approval was given by the ethics committee of the University of ErlangenNuremberg. The trial conformed to the principles of the Declaration of Helsinki and to the principles of Good Clinical Practice.
Quantitative Real-Time Polymerase Chain Reaction RNA extraction and quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) were performed as described previously [14, 15] . Illustra TM Mini RNA Isolation Kit (GE Healthcare, Buckinghamshire, UK) was used according to the manufacturer's instructions for isolation. 1 μg RNA (photometrically analyzed) was used for RT, obtaining 20 μl of the final volume (QuantiTect RT-Kit, Qiagen, Hilden, Germany). The qPCR was performed using qPCR-Core-Kit for SYBR-Green (Eurogentec, Cologne, Germany) and StepOnePlus Real-Time-PCR devices (Applied Biosystems, Darmstadt, Germany) (see online suppl. table S1 for primers; for all online suppl. material, see www.karger.com/doi/10.1159/000445781). Standard curves for quantifying the copy number of the target gene were generated using products from former test PCRs, which were extracted from agarose gel after electrophoresis. Serial dilutions (101-107) were allowed by the purified template cDNA. For quantification, the transcription level of the target gene was extrapolated from the standard curve equation and normalized to copies of beta-2-microglobulin (B2M), ribosomal-protein-S18 (RPS18) and hypoxanthin-guanin-phosphoribosyltransferase 1 (HPRT1) as endogenous reference gene. The geNorm software algorithm (http://medgen.ugent.be) was used.
Statistical Analysis mRNA expression data of qRT-PCR of patients were normalized using the median of the corresponding data of control subjects. By this, the deviation of the patients mRNA expression level from normal values could be demonstrated. Statistical calculations on the normalized data sets were carried out using an unpaired t test with Statistica 7 (Statsoft, Hamburg, Germany). p < 0.05 was considered as significant.
Western Blot Analysis
Western blot analysis was carried out as described before [14] . From each tissue sample, 25-40 mg were homogenized in 600 μl lysis buffer (50 m M Tris pH 7.4, 300 m M NaCl, 10 m M EDTA, 1% NP40, 0.1% Triton X-100, 0.1% SDS, protease inhibitor cocktail Complete ® , Roche, Mannheim, Germany), incubated and centrifuged. The protein concentration of the supernatant was analyzed using bicinchoninic acid assay (Pierce Biotechnology, Rockford, Ill., USA). Denaturation was accomplished at 90 ° C with SDS loading buffer and mercaptoethanol. 50 μg of lysate was applied to each lane, separated by SDS polyacrylamide gel electrophoresis (SDS-PAGE) on 10% gels and transferred to nitrocellulose membranes (Protran-BA-83, Schleicher & Schuell, Dassel, Germany). Anti-rat or anti-rabbit antibodies (KPL, Gaithersburg, Md., USA) diluted in RotiBlock, were applied, followed by peroxidase substrate SuperSignal West Dura or Pico (Thermo Scientific, Bonn, Germany) (for antibodies, see online suppl. table S2). Signals were detected by the LumiImager-F1 (Roche, Mannheim, Germany). Internal loading control was cytochrome c oxidase IV (COX IV).
Immunohistochemistry
Immunohistochemistry of paraffin sections using the block from the surgically derived tissue was performed in accordance with the manufacturer's instructions (Vector Laboratories, kit: Imm PRESS, substrate ImmPACT DAB). The sections were dried, deparaffinized and rehydrated through descending concentrations of ethanol. Heat-mediated antigen retrieval was performed using citrate buffer 0.01 M pH 6 or EDTA 1 m M in water pH 8-8.5 before being processed using the corresponding nAChR antibodies (for antibodies, see online suppl. table S2). Cell nuclei were counterstained with haemalaum at a pH of 2-3 in blue.
Results
Quantitative Real-Time PCR NM and SCC contain mRNA of α1, α3, α5 and α7. The exact graduation of transcript number is α7>α5>>α3>α1. A significant upregulation for nAChR α1 and α5 transcript levels was observed in SCC compared to NM (p = 0.014 and 0.0079) ( fig. 1 a) . Oropharyngeal tumors did not show significant changes in nAChR expression from NM to SCC ( fig. 1 b) . The hypopharynx reveals increased mRNA levels of nAChR α1 (p = 0.07/trend) in SCC ( fig. 1 c) . In SCC of the larynx, an upregulation for nAChR α1 transcript levels (p = 0.05) was detected. Here, α3 and α7 mRNA expressions were significantly downregulated (p = 0.03 for both) ( fig. 1 d) .
Immunoblotting
For the detection of nAChR α1, α3, α5 and α7 in SCC and NM, 50 μg of protein lysate from the tissue extract was used and processed as described in the Materials and Methods section. Western blot analysis confirmed the prior findings of the RT-PCR and revealed a reduced amount of nAChR α1 chain in oropharynx tumors compared to NM. Larynx and hypopharynx SCC showed converse proportions with a marked increase in nAChR α1 amount in SCC. Immunoblotting of nAChR α3 showed a reduced amount of receptors in laryngeal SCC and no significant difference in staining of SCC and NM of hypopharyngeal and oropharyngeal tissue. There was no significant change in nAChR α5 and α7 subunit amount between SCC and NM in all sections of the upper aerodigestive tract. There was slightly more intense staining in NM than in SCC for α5 in the oropharynx and for α7 in the larynx. COX IV was used as an internal mitochondrial loading control. Here, all bands show equal staining proving the same amount of protein on the gel ( fig. 2 ) . 
Immunohistochemistry
All squamous cell carcinomas showed intense staining of the nAChR subunits. In densely aggregated tumor cells, staining for α1, α3 and α7 subunits was highly visible. In these cells, especially α3 showed a clod-like nAChR arrangement. The tumor invasion zones were more intensely stained for nAChR α7 subunit than the remaining tumor areas. The α1 and α5 subunits were spread up equally throughout the tumor ( fig. 3 ) .
Relationship of nAChR Subunit Expression Patterns to Clinicopathologic Features
The main clinicopathologic features are summarized in table 1 . The grading groups were merged as G1-2 and G3-4. With increasing Union for International Cancer Control (UICC) stage and grading (G status), the mRNA expression of the nAChR subunits α1, α3, α5 and α7 generally showed an increase, significant at the G status for α5 (p = 0.002). α1, α3 and α7 had the same pattern, though not significant due to the small number of patients. As for UICC stage, the mRNA expression in SCC relative to NM indicated a significant increase of the α1 subunit for UICC III and IVa (p = 0.04 and 0.01) and an elevation of α5 for UICC III (p = 0.06/ trend) and IVa (p = 0.002). Interestingly, α7 in UICC I showed a significant decrease of mRNA expression relative to NM (p = 0.008). There were no changes in α3 ( fig. 4 ) . Immunoblots of nAChRs from NM and SCC of oropharynx, hypopharynx and larynx using primary antibodies against nAChR. 60-kDa bands are shown. A decreased amount of α1 in oropharynx SCC compared to NM was detected, while hypopharynx and larynx SCC showed a marked increase in staining of SCC. No significant difference between SCC and NM regarding the amount of nAChR α5 was found at any sites. The α3 and α7 subunits revealed less intense bands in laryngeal SCC than in NM. COX IV functioning as a loading control showed equal bands everywhere. 
Discussion
In this study, we demonstrate for the first time the exact presence, quantity and cancerous change of the nAChR subtypes α1, α3, α5 and α7 in aerodigestive tract mucosa combined with a tumor progression correlation analysis. The level of the expression depends upon the anatomical site, upon whether the mucosa is healthy or cancerous and on the stage of tumor progression. We found the general expression of α7 and α5 mRNA in both NM and SCC to be higher than the amount of α1 and α3 ( fig. 1 a) . Arredondo et al. [11] have found a similar sequence in oral keratinocytes.
Functional α5 subunits change channel conformation when coexpressed with other receptors and are characterized by a modulatory role. α5 and α7 subunits both coassemble with β2 and α3 to form heteropentamers [11] , explaining why SCC and NM include comparable amounts of α5 and α7, both in higher portions than α1 and α3 subunits.
It is known that the nAChR subunit α1 is present on bronchial epithelial cells [16] , macrophages [17] , thymocytes [18] and muscle [2] . To our knowledge, the nAChR subunit α1 has never been described in the upper aerodigestive tract. Here, we found a presence of this subunit at all mucosal sites with an upregulation in SCC of larynx and hypopharynx.
In laryngeal SCC, α3 and α7 expression is suppressed. In bronchial epithelium and keratinocytes, nAChRs are conductive to epithelial stability [19] . The lack of cell stability in SCC could result in a downregulation of α3 and α7 nAChR. The amount of transcripts could be influenced by events before or after transcription, such as subunit mRNA instability itself, as was demonstrated in a report about acetylcholinesterase in C2C12 cells [20] .
Carracedo et al. [21] examined α3 mRNA expression by RT-PCR in laryngeal SCC, which was negative and partly coherent with our data, where the α3 subunit is 3.6-fold less expressed than in NM. Upon a conformation change of the cell surface, α3 subunits are internalized and degraded in lysosomes and are no longer detectable [12] . Figure 3 shows a clod-like α3 arrangement indicating internalized α3 spots. In lysosomes, autophagy takes place and is involved in type II programmed cell death. Nicotine has been reported to induce autophagy by binding to nAChRs as a protective response of vocal fold fibroblasts [22] .
Nicotine promotes the growth of cancer cell populations, suggesting that it might contribute to the progression of already initiated tumors [23] . This confirms our findings of a correlation between tumor grading, raising UICC stage and the level of mRNA expression of some nAChR subunits.
Conclusion
(1) nAChR subunits α1, α3, α5 and α7 are found ubiquitously in the upper aerodigestive tract mucosa with a high concentration of α5 and α7. (2) Particularly in the larynx and partly in the hypopharynx, a significant difference in NM and SCC of nAChR subtype distribution was found at both RNA and protein level. The nAChR subunit distribution may be useful in identifying carcinogenic mucosal changes from NM to SCC. For this, further investigations are necessary. (3) Advanced tumors show an increase in α1 and α5 and a decrease in α7 transcript levels. The findings can provide a basis for further studies of tumor characterization such as prognostic evaluation by measuring the specific change in the nAChR subunit distribution with tumor progression.
